These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 15349956)

  • 1. Development of stable liquid formulations for adenovirus-based vaccines.
    Evans RK; Nawrocki DK; Isopi LA; Williams DM; Casimiro DR; Chin S; Chen M; Zhu DM; Shiver JW; Volkin DB
    J Pharm Sci; 2004 Oct; 93(10):2458-75. PubMed ID: 15349956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of degradation pathways for plasmid DNA in pharmaceutical formulations via accelerated stability studies.
    Evans RK; Xu Z; Bohannon KE; Wang B; Bruner MW; Volkin DB
    J Pharm Sci; 2000 Jan; 89(1):76-87. PubMed ID: 10664540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilization and formulation of a recombinant Human Cytomegalovirus vector for use as a candidate HIV-1 vaccine.
    Kumru OS; Saleh-Birdjandi S; Antunez LR; Sayeed E; Robinson D; van den Worm S; Diemer GS; Perez W; Caposio P; Früh K; Joshi SB; Volkin DB
    Vaccine; 2019 Oct; 37(44):6696-6706. PubMed ID: 31548012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Algorithm-Based Liquid Formulation Development Including a DoE Concept Predicts Long-Term Viral Vector Stability.
    Reinauer EB; Grosso SS; Henz SR; Rabas JA; Rodenstein C; Altrichter J; Scholz M; Kemter KF
    J Pharm Sci; 2020 Jan; 109(1):818-829. PubMed ID: 31689430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for improved stability of Peste des Petits Ruminants Vaccine.
    Silva AC; Carrondo MJ; Alves PM
    Vaccine; 2011 Jul; 29(31):4983-91. PubMed ID: 21570436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Freeze-Drying Formulations Increased the Adenovirus and Poxvirus Vaccine Storage Times and Antigen Stabilities.
    Chen Y; Liao Q; Chen T; Zhang Y; Yuan W; Xu J; Zhang X
    Virol Sin; 2021 Jun; 36(3):365-372. PubMed ID: 32696399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
    Mayr GA; Chinsangaram J; Grubman MJ
    Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and characterization of a replication-competent human adenovirus type 3-based vector as a live-vaccine candidate and a viral delivery vector.
    Zhang Q; Su X; Seto D; Zheng BJ; Tian X; Sheng H; Li H; Wang Y; Zhou R
    Vaccine; 2009 Feb; 27(8):1145-53. PubMed ID: 19146906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of yellow fever vaccine.
    Monath TP
    Dev Biol Stand; 1996; 87():219-25. PubMed ID: 8854020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric adenovirus 5/35 vector containing the clade C HIV gag gene induces a cross-reactive immune response against HIV.
    Xin KQ; Sekimoto Y; Takahashi T; Mizuguchi H; Ichino M; Yoshida A; Okuda K
    Vaccine; 2007 May; 25(19):3809-15. PubMed ID: 17386962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of adenovirus as a model system to illustrate a simple method using standard equipment and inexpensive excipients to remove live virus dependence on the cold-chain.
    Stewart M; Ward SJ; Drew J
    Vaccine; 2014 May; 32(24):2931-8. PubMed ID: 24662703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective immunity to rotavirus-induced diarrhoea is passively transferred to newborn mice from naive dams vaccinated with a single dose of a recombinant adenovirus expressing rotavirus VP7sc.
    Both GW; Lockett LJ; Janardhana V; Edwards SJ; Bellamy AR; Graham FL; Prevec L; Andrew ME
    Virology; 1993 Apr; 193(2):940-50. PubMed ID: 8384761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection and visualization of human adenovirus serotype 5-viral vectors carrying foot-and-mouth disease virus or luciferase transgenes in cell lines and bovine tissues.
    Montiel N; Smoliga G; Arzt J
    Vaccine; 2012 Feb; 30(9):1690-701. PubMed ID: 22227230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel formulations enhance the thermal stability of live-attenuated flavivirus vaccines.
    Wiggan O; Livengood JA; Silengo SJ; Kinney RM; Osorio JE; Huang CY; Stinchcomb DT
    Vaccine; 2011 Oct; 29(43):7456-62. PubMed ID: 21803103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation development of a plant-derived H1N1 influenza vaccine containing purified recombinant hemagglutinin antigen.
    Iyer V; Liyanage MR; Shoji Y; Chichester JA; Jones RM; Yusibov V; Joshi SB; Middaugh CR
    Hum Vaccin Immunother; 2012 Apr; 8(4):453-64. PubMed ID: 22370514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Characterization and Formulation Development of a Trivalent Equine Encephalitis Virus-Like Particle Vaccine Candidate.
    Toprani VM; Cheng Y; Wahome N; Khasa H; Kueltzo LA; Schwartz RM; Middaugh CR; Joshi SB; Volkin DB
    J Pharm Sci; 2018 Oct; 107(10):2544-2558. PubMed ID: 29883665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designed recombinant adenovirus type 5 vector induced envelope-specific CD8(+) cytotoxic T lymphocytes and cross-reactive neutralizing antibodies against human immunodeficiency virus type 1.
    Ura T; Yoshida A; Xin KQ; Yoshizaki S; Yashima S; Abe S; Mizuguchi H; Okuda K
    J Gene Med; 2009 Feb; 11(2):139-49. PubMed ID: 19065543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of formulation properties on chemical stability of captopril in aqueous preparations.
    Kristensen S; Lao YE; Brustugun J; Braenden JU
    Pharmazie; 2008 Dec; 63(12):872-7. PubMed ID: 19177902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational design of a stable, freeze-dried virus-like particle-based vaccine formulation.
    Lang R; Winter G; Vogt L; Zurcher A; Dorigo B; Schimmele B
    Drug Dev Ind Pharm; 2009 Jan; 35(1):83-97. PubMed ID: 19016059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and characterization of a recombinant human adenovirus type 3 vector containing two foreign neutralizing epitopes in hexon.
    Xue C; Tian X; Li X; Zhou Z; Su X; Zhou R
    Virus Res; 2014 Apr; 183():67-74. PubMed ID: 24518297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.